GlycoDesign is Drug Discovery in Canada that focus on chronic inflammatory business. Founded in 1993. They cover business area such as developer, proprietary drug, prevention, cardiovascular and chronic inflammatory disease, cancer, two anti-thrombotic drug candidate, ATH, glycotherapeutic, chronic inflammation.
1993
( 31 years old in 2024 )
Chronic Inflammatory
-
400-480 University Avenue
Toronto, Ontario M5G 1V2
Canada
Private
developerproprietary drugpreventioncardiovascular and chronic inflammatory diseasecancertwo anti-thrombotic drug candidateATHglycotherapeuticchronic inflammation
* We use standard office opening hours in near GlycoDesign's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
GlycoDesign is Drug Discovery business from Canada that founded in 1993 (31 years old in 2024), GlycoDesign business is focusing on Chronic Inflammatory.
GlycoDesign headquarter office and corporate office address is located in 400-480 University Avenue Toronto, Ontario M5G 1V2 Canada.
GlycoDesign was founded in Canada.
In 2024, GlycoDesign is currently focus on chronic inflammatory sector.
Above is snippet of Google Trends for "chronic inflammatory" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with GlycoDesign, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
